drugset / Trial / NCT03304938

Lavender Aromatherapy on Sleep Quality and Metabolic Parameters of Type 2 Diabetic Patients With Insomnia

NCT03304938

RandomizedCrossoverQuadruple-blindTreatment

Summary

This study is designed as cross-over double-blind placebo-controlled randomized clinical trial that 40 diabetic patients with sleep disorder with the inclusion criteria will enter into the study and randomly assign to first intervention and first placebo groups.The primary outcomes are change in sleep disorder and metabolic parameters that will be evaluated at the end of the study.

Timeline

Start
2018-02-01
Primary completion
2018-11-01
Completion
2018-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lavender Oil Other / unclassified 3 unknown Inhaled